Intravenous-Morphine and Glucagon-Usage Enhanced MR Cholangiography

Phase 4

• Conditions: Liver Disease

• Registration Number: NCT00155376
• Lead Sponsor: National Taiwan University Hospital

Brief Summary

Morphine can induce constriction of sphincter of oddi and glucagon can facilitate bile secretion and dilatation of bile duct. We conduct this randomized double blinded study to evaluate the effect of enhancement in MRCP using intravenous morphine and glucagon.

Detailed Description

Morphine can induce constriction of sphincter of oddi and glucagon can facilitate bile secretion and dilatation of bile duct. We conduct this randomized double blinded study to evaluate the effect of enhancement in MRCP using intravenous morphine and glucagon.

Study Timeline

• Status Verified: 2005-04
• Study Start: 2005-09
• Study Completion: 2005-09
• Study First Submitted: 2005-09-08
• Study First Submitted QC: 2005-09-08
• Study First Posted: 2005-09-12
• Last Update Submitted: 2005-11-25
• Last Update Posted: 2005-11-28

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• normal volunteer
• living liver donor

Exclusion Criteria

• COPD
• chronic liver disease
• hypersensitive to glucagon
• DM
• insulinoma
• glucagonoma
• pregnancy

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
MRCP visibility

Trial Locations

Locations (1)

National Taiwan University Hospital; 🇨🇳 Taipei, province of Taiwan, Taiwan